Search - tctmd.com

Displaying 161 - 180 of 345

Sort: Relevancy | Date

Presentation THT 2022

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Physiological Rationale and Devices for Interatrial Shunts

Presenter: JoAnn Lindenfeld

February 01, 2022

Presentation THT 2022

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Liviu Klein

February 01, 2022

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Presenter: Harlee Sorkin

November 05, 2021

Presentation TCT 2021

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Presenter: Jacob Kriegel

November 05, 2021

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

News Daily News

New Data Back Closing Large PFOs to Prevent Decompression Sickness in Divers

Yael L. Maxwell

August 19, 2021

Presentation TVT 2021

Interatrial Shunts for Heart Failure: Physiological and Device Concepts

Presenter: JoAnn Lindenfeld

July 22, 2021

Presentation TVT 2021

Implant-Free Intra-Atrial Shunt (Alleviant)

Presenter: Christopher Meduri

July 22, 2021

News Industry News

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

July 14, 2021

News Daily News

PFO Closure for Migraine: Pooled Analysis Hints at Benefit Over Meds Alone

Yael L. Maxwell

February 09, 2021

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

Presentation TCT 2020

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Presenter: Daniel Burkhoff

October 17, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

Advertisement

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Physiological Rationale and Devices for Interatrial Shunts

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

New Data Back Closing Large PFOs to Prevent Decompression Sickness in Divers

Interatrial Shunts for Heart Failure: Physiological and Device Concepts

Implant-Free Intra-Atrial Shunt (Alleviant)

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

PFO Closure for Migraine: Pooled Analysis Hints at Benefit Over Meds Alone

NorthShore University Health System

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content